Related references
Note: Only part of the references are listed.Age and immunity: What is immunosenescence?
Graham Pawelec
EXPERIMENTAL GERONTOLOGY (2018)
Characterization of liver injury induced by cancer immunotherapy using immune checkpoint inhibitors
Eleonora De Martin et al.
JOURNAL OF HEPATOLOGY (2018)
Ageing: from inflammation to cancer
Giulia C. Leonardi et al.
IMMUNITY & AGEING (2018)
Association of Immunotherapy With Overall Survival in Elderly Patients With Melanoma
Marie Perier-Muzet et al.
JAMA DERMATOLOGY (2018)
Efficacy of PD-1 & PD-L1 inhibitors in older adults: a meta-analysis
Rawad Elias et al.
JOURNAL FOR IMMUNOTHERAPY OF CANCER (2018)
MYOCARDITIS AND RHABDOMYOLYSIS INCIDENCE WITH IMMUNE CHECKPOINT INHIBITORS
Tyler Bloomer et al.
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY (2017)
Checkpoint inhibition and melanoma: Considerations in treating the older adult Checkpoint inhibition and melanoma: Considerations in treating the older adult
Claire F. Friedman et al.
JOURNAL OF GERIATRIC ONCOLOGY (2017)
Rheumatoid arthritis and polymyalgia rheumatica occurring after immune checkpoint inhibitor treatment
Rakiba Belkhir et al.
ANNALS OF THE RHEUMATIC DISEASES (2017)
Comparison of efficacy of immune checkpoint inhibitors (ICIs) between younger and older patients: A systematic review and meta-analysis
Tomohiro F. Nishijima et al.
CANCER TREATMENT REVIEWS (2016)
Cutaneous, gastrointestinal, hepatic, endocrine, and renal side-effects of anti-PD-1 therapy
Lars Hofmann et al.
EUROPEAN JOURNAL OF CANCER (2016)
Clinicopathological features of acute kidney injury associated with immune checkpoint inhibitors
Frank B. Cortazar et al.
KIDNEY INTERNATIONAL (2016)
The development of immunotherapy in older adults: New treatments, new toxicities?
Carole Helissey et al.
JOURNAL OF GERIATRIC ONCOLOGY (2016)
Responses to immune checkpoint inhibitors in nonagenarians
Romany A. N. Johnpulle et al.
ONCOIMMUNOLOGY (2016)
Is there a clinical benefit of anti-PD-1 in patients older than 75 years with previously treated solid tumour?
Thierry Landre et al.
JOURNAL OF CLINICAL ONCOLOGY (2016)
The management of cancer in the elderly: targeted therapies in oncology
Biagio Agostara et al.
Immunity & Ageing (2008)
Frailty in older adults: Evidence for a phenotype
LP Fried et al.
JOURNALS OF GERONTOLOGY SERIES A-BIOLOGICAL SCIENCES AND MEDICAL SCIENCES (2001)
Share Paper
